MedPath

LSB (HK) LIMITED

🇭🇰Hong Kong, China
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

176

PPB:176

Drug Approvals

ALBISTA CAPSULES

Approval Date
Nov 6, 2024
PPB

MEVODEX EYE OINTMENT

Approval Date
Oct 22, 2024
PPB

HAPPILONG TABLETS 5MG

Approval Date
Nov 6, 2023
PPB

KINCEF TABLETS 250MG

Approval Date
Jan 26, 2023
PPB

METAVON TABLETS 8MG

Approval Date
Nov 2, 2021
PPB

NONANTI TABLETS 50MG

Approval Date
Aug 12, 2021
PPB

KELTREX CAPSULES 100MG

Approval Date
Jun 5, 2020
PPB

SYNUS NASAL SPRAY 0.05% W/V

Approval Date
Sep 27, 2019
PPB

PHARVIS AMBROXOL TABLETS 30MG

Approval Date
Apr 16, 2019
PPB

VICURE TABLETS 0.5MG

Approval Date
Dec 1, 2018
PPB
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 18
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.